Search research articles
Contact Us
Filters
Showing results (501-510 of 518) with videos related to
Page
of 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2019
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial
Jianming Xu, Jie Li, Chunmei Bai, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 26, 2022
Association of Long-term Ambient Fine Particulate Matter (PM<sub>2.5</sub>) and Incident CKD: A Prospective Cohort Study in China
Jing-Wen Duan, Ya-Lan Li, Shen-Xin Li, et al.
Nature
|
October 1, 2025
Long-distance remote epitaxy
Ru Jia, Yan Xin, Mark Potter, et al.
Signal Transduction and Targeted Therapy
|
October 12, 2025
First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study
Ru Jia, Hai-Yan Si, Meng-Jiao Fan, et al.
Eclinicalmedicine
|
October 3, 2022
S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial
Yihebali Chi, Lijie Song, Weili Liu, et al.
Frontiers in Oncology
|
March 22, 2021
Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ru Jia, Ningning Liu, Guoxiang Cai, et al.
Journal of Thoracic Disease
|
September 4, 2018
Viral infection in community acquired pneumonia patients with fever: a prospective observational study
Ru-Jia Tao, Xiao-Li Luo, Wen Xu, et al.
Nature
|
July 21, 2022
Giant pyroelectricity in nanomembranes
Jie Jiang, Lifu Zhang, Chen Ming, et al.
Science Advances
|
April 3, 2021
Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype
Changxiu Qu, Chunyou Mao, Peng Xiao, et al.
Cancer Communications (London, England)
|
April 20, 2026
First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
Ru Jia, Yan-Rong Wang, Fang-Fang Liu, et al.
Page
of 52
Search research articles
Search
Showing results (501-510 of 518) with videos related to
Sort By:
Page
of 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2019
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial
Jianming Xu, Jie Li, Chunmei Bai, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 26, 2022
Association of Long-term Ambient Fine Particulate Matter (PM<sub>2.5</sub>) and Incident CKD: A Prospective Cohort Study in China
Jing-Wen Duan, Ya-Lan Li, Shen-Xin Li, et al.
Nature
|
October 1, 2025
Long-distance remote epitaxy
Ru Jia, Yan Xin, Mark Potter, et al.
Signal Transduction and Targeted Therapy
|
October 12, 2025
First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study
Ru Jia, Hai-Yan Si, Meng-Jiao Fan, et al.
Eclinicalmedicine
|
October 3, 2022
S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial
Yihebali Chi, Lijie Song, Weili Liu, et al.
Frontiers in Oncology
|
March 22, 2021
Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Ru Jia, Ningning Liu, Guoxiang Cai, et al.
Journal of Thoracic Disease
|
September 4, 2018
Viral infection in community acquired pneumonia patients with fever: a prospective observational study
Ru-Jia Tao, Xiao-Li Luo, Wen Xu, et al.
Nature
|
July 21, 2022
Giant pyroelectricity in nanomembranes
Jie Jiang, Lifu Zhang, Chen Ming, et al.
Science Advances
|
April 3, 2021
Ligand recognition, unconventional activation, and G protein coupling of the prostaglandin E<sub>2</sub> receptor EP2 subtype
Changxiu Qu, Chunyou Mao, Peng Xiao, et al.
Cancer Communications (London, England)
|
April 20, 2026
First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
Ru Jia, Yan-Rong Wang, Fang-Fang Liu, et al.
Page
of 52